Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Research presented at ASM Microbe has reported a Zika vaccine based on the NS1 protein can induce protective immunity in mouse models after a single dose.
A new first-of-its-kind study will assess Zika virus as a tool to target glioblastomas, one of the most challenging cancers to treat.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis.
Researchers have uncovered a mechanism utilized by Zika virus to cross the placental barrier; this has provided an insight into the virus’ ability to cause birth defects such as microcephaly.